Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania

OBJECTIVES: A randomized double-blind placebo-controlled trial (RCT) of HSV-2 suppressive therapy with acyclovir 400mg b.d. conducted among women in northwestern Tanzania reported a similar rate of HIV acquisition in both trial arms (Current Controlled Trials number ISRCTN35385041). Risk factors for...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Watson-Jones, Deborah, Baisley, Kathy, Weiss, Helen A, Tanton, Clare, Changalucha, John, Everett, Dean, Chirwa, Tobias, Ross, David, Clayton, Tim, Hayes, Richard
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3223401/
https://ncbi.nlm.nih.gov/pubmed/19114859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e32831ef523
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller